Metabolites
Displaying metabolites 2226 - 2250 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB23300 | DG(18:0/16:1(9Z)/0:0) | (2S)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl octadecanoate | phospholipid biosynthesis (PE(18:0/16:1(9Z))) PW001770 | 594.962 C37H70O5 | |
ECMDB23308 | DG(18:1(9Z)/16:0/0:0) | (2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(18:1(9Z)/16:0/16:0/19:0cycv8c) 2) PW001783 | 594.962 C37H70O5 | |
ECMDB23316 | DG(19:1(9Z)/15:0/0:0) | (2R)-2-hydroxy-3-(pentadecanoyloxy)propyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (CL(15:0cyclo/15:0cyclo/19:0cycv8c/19:0cycv8c)) PW001789 | 594.962 C37H70O5 | |
ECMDB21591 | PE(10:0/15:0) | (2-aminoethoxy)[(2R)-3-(decanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/15:0) III PW001825 | 593.7731 C30H60NO8P | |
ECMDB21613 | PE(15:0/10:0) | (2-aminoethoxy)[(2R)-2-(decanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid | 593.7731 C30H60NO8P | ||
ECMDB24790 | DG(15:0cyclo/19:0cycv8c/0:0) | (2R)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 10-(2-hexylcyclopropyl)decanoate | phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:0/16:0) PW001189 | 592.946 C37H68O5 | |
ECMDB24809 | DG(17:0cycw7c/17:0cycw7c/0:0) | 3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 8-(2-hexylcyclopropyl)octanoate | 592.946 C37H68O5 | ||
ECMDB24820 | DG(19:0cycv8c/15:0cyclo/0:0) | (2S)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 10-(2-hexylcyclopropyl)decanoate | 592.946 C37H68O5 | ||
ECMDB23293 | DG(16:1(9Z)/18:1(9Z)/0:0) | (2S)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(16:1(9Z)/18:1(9Z)/16:1(9Z)/14:0)) PW001759 | 592.946 C37H68O5 | |
ECMDB23309 | DG(18:1(9Z)/16:1(9Z)/0:0) | (2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(18:1(9Z)/16:1(9Z)/19:0cycv8c/18:1(9Z)) 2) PW001784 | 592.946 C37H68O5 | |
ECMDB21460 | Ubiquinol-6 5677-58-7 | 2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5,6-dimethoxy-3-methylbenzene-1,4-diol | TCA cycle (ubiquinol-6) PW001006 | 592.8913 C39H60O4 | |
ECMDB20620 | Ubiquinone-6 1065-31-2 | 2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | TCA cycle (ubiquinol-6) PW001006 | 590.8754 C39H58O4 | |
ECMDB20470 | Dimyristoyl phosphatidate | (2R)-1-(phosphonatooxy)-3-(tetradecanoyloxy)propan-2-yl tetradecanoate | 590.7691 C31H59O8P | ||
ECMDB21000 | D-Urobilinogen 17208-65-0 | 3-(2-{[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl}-5-[(3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl)propanoic acid | 590.7098 C33H42N4O6 | ||
ECMDB23903 | dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose | {[(2R,3R,4S,5R,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}({[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid | 589.384 C18H29N3O15P2 | ||
ECMDB20613 | dTDP-4-Acetamido-4,6-dideoxy-D-galactose | {[(3R,4S,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}({[hydroxy({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid | Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 | 589.3815 C18H29N3O15P2 | |
ECMDB23181 | TDP-Fuc4NAc | [({[(2R,3R,4S,5R,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | 589.3815 C18H29N3O15P2 | ||
ECMDB01095 | GDP-L-Fucose 15839-70-0 | [({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phosphinic acid | 589.3417 C16H25N5O15P2 | ||
ECMDB06557 | ADP-Glucose 2140-58-1 | [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | 589.3417 C16H25N5O15P2 | ||
ECMDB24243 | GDP-β-L-fucose | [5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(3,4,5-trihydroxy-6-methyloxan-2-yl phosphonato)oxy]phosphonate | Amino sugar and nucleotide sugar metabolism II PW000887 | 587.329 C16H23N5O15P2 | |
ECMDB01346 | GDP-4-Dehydro-6-deoxy-D-mannose 18186-48-6 | [({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,6R)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl]oxy})phosphinic acid | 587.3258 C16H23N5O15P2 | ||
ECMDB01391 | GDP-4-Dehydro-6-L-deoxygalactose | [({[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(3,4-dihydroxy-6-methyl-5-oxooxan-2-yl)oxy]phosphinic acid | Amino sugar and nucleotide sugar metabolism II PW000887 | 587.3258 C16H23N5O15P2 | |
ECMDB21433 | Adenosine tetraphosphate 58337-43-2 | {[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}phosphonic acid | D-Glutamine and D-glutamate metabolism PW000769 | 587.1609 C10H17N5O16P4 | |
ECMDB23632 | PG(10:0(3-OH)/10:0(3-OH)) | [(2R)-2,3-bis[(3-hydroxydecanoyl)oxy]propoxy][(2S)-2,3-dihydroxypropoxy]phosphinic acid | phospholipid biosynthesis (CL(18:0/10:0/10:0/10:0)) PW001974 | 586.656 C26H51O12P | |
ECMDB24242 | GDP-4-dehydro-6-deoxy-α-D-mannose | 9-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,6R)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl]oxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-2-imino-3,9-dihydro-2H-purin-6-olate | Amino sugar and nucleotide sugar metabolism II PW000887 | 585.313 C16H21N5O15P2 |